Tse-Siang Kang - Publications

2008-2010 Pharmacy National University of Singapore, Singapore, Singapore 

18 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Darvish-Damavandi M, Ho HK, Kang TS. Towards the development of an enzyme replacement therapy for the metabolic disorder propionic acidemia. Molecular Genetics and Metabolism Reports. 8: 51-60. PMID 27504265 DOI: 10.1016/j.ymgmr.2016.06.009  0.88
2015 Bahk YM, Kang BJ, Kim YS, Kim JY, Kim WT, Kim TY, Kang T, Rhie J, Han S, Park CH, Rotermund F, Kim DS. Electromagnetic Saturation of Angstrom-Sized Quantum Barriers at Terahertz Frequencies. Physical Review Letters. 115: 125501. PMID 26431000 DOI: 10.1103/Physrevlett.115.125501  0.4
2015 Shin Y, Song J, Kim D, Kang T. Facile Preparation of Ultrasmall Void Metallic Nanogap from Self-Assembled Gold-Silica Core-Shell Nanoparticles Monolayer via Kinetic Control. Advanced Materials (Deerfield Beach, Fla.). PMID 26111993 DOI: 10.1002/adma.201501163  0.44
2015 Kang E, Seong MW, Park SK, Lee JW, Lee J, Kim LS, Lee JE, Kim SY, Jeong J, Han SA, Kim SW. The prevalence and spectrum of BRCA1 and BRCA2 mutations in Korean population: recent update of the Korean Hereditary Breast Cancer (KOHBRA) study. Breast Cancer Research and Treatment. 151: 157-68. PMID 25863477 DOI: 10.1007/s10549-015-3377-4  0.4
2015 Song J, Kang TH, Kim MW, Han S. Ion specific effects: decoupling ion-ion and ion-water interactions. Physical Chemistry Chemical Physics : Pccp. 17: 8306-22. PMID 25761273 DOI: 10.1039/C4Cp05992A  0.44
2015 Chen W, Carvalho LP, Chan MY, Kini RM, Kang TS. Fasxiator, a novel factor XIa inhibitor from snake venom, and its site-specific mutagenesis to improve potency and selectivity. Journal of Thrombosis and Haemostasis : Jth. 13: 248-61. PMID 25418421 DOI: 10.1111/jth.12797  0.88
2015 Jung EG, Shin Y, Lee M, Yi J, Kang T. Interfacial Synthesis of Two-Dimensional Dendritic Platinum Nanoparticles Using Oleic Acid-in-Water Emulsion Acs Applied Materials and Interfaces. 7: 10666-10670. DOI: 10.1021/acsami.5b02433  0.44
2014 Chen W, Goh LC, Kang TS, Kini RM. Identification and characterisation of novel inhibitors on extrinsic tenase complex from Bungarus fasciatus (banded krait) venom. Thrombosis and Haemostasis. 112: 700-15. PMID 25008365 DOI: 10.1160/TH13-12-1063  0.88
2014 Damavandi MD, Chan EC, Kraus JP, Ho PC, Kang TS. Development of an UPLC-MS/MS method for assaying the enzymatic activity of propionyl coenzyme-A carboxylase. Bioanalysis. 6: 335-48. PMID 24471954 DOI: 10.4155/bio.13.297  0.88
2014 Ho HK, Yeo AH, Kang TS, Chua BT. Current strategies for inhibiting FGFR activities in clinical applications: opportunities, challenges and toxicological considerations. Drug Discovery Today. 19: 51-62. PMID 23932951 DOI: 10.1016/J.Drudis.2013.07.021  0.88
2011 Sarkissian CN, Kang TS, Gámez A, Scriver CR, Stevens RC. Evaluation of orally administered PEGylated phenylalanine ammonia lyase in mice for the treatment of Phenylketonuria. Molecular Genetics and Metabolism. 104: 249-54. PMID 21803624 DOI: 10.1016/J.Ymgme.2011.06.016  0.88
2010 Kang TS, Wang L, Sarkissian CN, Gámez A, Scriver CR, Stevens RC. Converting an injectable protein therapeutic into an oral form: phenylalanine ammonia lyase for phenylketonuria. Molecular Genetics and Metabolism. 99: 4-9. PMID 19793667 DOI: 10.1016/J.Ymgme.2009.09.002  0.88
2009 Kang TS, Stevens RC. Structural aspects of therapeutic enzymes to treat metabolic disorders. Human Mutation. 30: 1591-610. PMID 19790257 DOI: 10.1002/Humu.21111  0.88
2009 Kang TS, Kini RM. Structural determinants of protein folding. Cellular and Molecular Life Sciences : Cmls. 66: 2341-61. PMID 19367367 DOI: 10.1007/S00018-009-0023-5  0.88
2007 Kang TS, Radi? Z, Talley TT, Jois SD, Taylor P, Kini RM. Protein folding determinants: structural features determining alternative disulfide pairing in alpha- and chi/lambda-conotoxins. Biochemistry. 46: 3338-55. PMID 17315952 DOI: 10.1021/Bi061969O  0.88
2006 Kang TS, Jois SD, Kini RM. Solution structures of two structural isoforms of CMrVIA chi/lambda-conotoxin. Biomacromolecules. 7: 2337-46. PMID 16903680 DOI: 10.1021/Bm060269W  0.88
2005 Kang TS, Vivekanandan S, Jois SD, Kini RM. Effect of C-terminal amidation on folding and disulfide-pairing of alpha-conotoxin ImI. Angewandte Chemie (International Ed. in English). 44: 6333-7. PMID 16161170 DOI: 10.1002/Anie.200502300  0.88
2005 Choi EY, Kwon HM, Ahn CW, Lee GT, Joung B, Hong BK, Yoon YW, Kim D, Byun KH, Kang TS, Yoon SJ, Kwon SW, Lee SJ, Park JK, Kim HS. Serum levels of advanced glycation end products are associated with in-stent restenosis in diabetic patients. Yonsei Medical Journal. 46: 78-85. PMID 15744809  0.44
Show low-probability matches.